Workflow
威高股份:威高血净拟发行对价股份收购威高普瑞100%的股权
Zhi Tong Cai Jing·2025-10-17 14:24

Core Points - Weigao Group has signed a non-binding letter of intent to acquire 100% equity of Weigao Puri through Weigao Blood Purification [1] - Weigao Blood Purification specializes in the research, production, and sales of medical products for blood purification, including hemodialysis devices and peritoneal dialysis solutions [1] - Weigao Puri focuses on the development and production of pre-filled drug delivery systems and automatic safety drug delivery systems, providing comprehensive drug delivery solutions for global biopharmaceutical companies [1] Business Synergy - The potential transaction is expected to create business synergies between Weigao Puri and Weigao Blood Purification, further expanding the overall business landscape of the group [2]